IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
Yazeed Sawalhamonoclonal_antibodyPhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
24 Active assets in the Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Mayo Clinic | Phase 2 | B |
DEXAMETHASONE National Cancer Institute (NCI) | Phase 2 | B |
Ibrutinib National Cancer Institute (NCI) | Phase 2 | B |
Epirubicin Mayo Clinic | Phase 2 | CCC |
Nivolumab National Cancer Institute (NCI) | Phase 2 | CCC |
View all 31 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →